Circulating tumour DNA (ctDNA) as a liquid biopsy for melanoma
Open Access
- 4 July 2017
- journal article
- review article
- Published by Elsevier BV in Cancer Letters
- Vol. 404, 62-69
- https://doi.org/10.1016/j.canlet.2017.06.030
Abstract
No abstract availableKeywords
Funding Information
- Western Australia Cancer Council (1100249)
This publication has 83 references indexed in Scilit:
- Signatures of mutational processes in human cancerNature, 2013
- Detection of MGMT, RASSF1A, p15INK4B, and p14ARF promoter methylation in circulating tumor-derived DNA of central nervous system cancer patientsJournal of Applied Genetics, 2013
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast CancerThe New England Journal of Medicine, 2013
- AIM1 and LINE-1 Epigenetic Aberrations in Tumor and Serum Relate to Melanoma Progression and Disease OutcomeJournal of Investigative Dermatology, 2012
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in CancerThe New England Journal of Medicine, 2012
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E MutationThe New England Journal of Medicine, 2011
- Distinctive DNA methylation patterns of cell-free plasma DNA in women with malignant ovarian tumorsGynecologic Oncology, 2011
- Methylation patterns in cell‐free plasma DNA reflect removal of the primary tumor and drug treatment of breast cancer patientsInternational Journal of Cancer, 2010
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaThe New England Journal of Medicine, 2010
- Cell-free and cell-bound circulating DNA in breast tumours: DNA quantification and analysis of tumour-related gene methylationBritish Journal of Cancer, 2006